HER3 – APBN New Site

Precision Medicine Using Innovative Biotherapeutics

April 15, 2020 . Posted in Spotlights

In early January 2020, Hummingbird Bioscience published preclinical data showcasing the efficacy of its anti-HER3 antibody known as HMBD-001 (also known as 10D1F.1) The findings demonstrate the...

Preclinical Data Demonstrates Favourable Safety Profile of Novel Anti-HER3 Antibody

February 17, 2020 . Posted in Inside Industry

Hummingbird Bioscience published in January 2020 preclinical data of its lead candidate, HMBD-001, in Molecular Cancer Therapeutics. Innovative biotherapeutics company, Hummingbird Bioscience,...